Axis Securities is of the view that pharma companies under its coverage shall continue to showcase high single digit growth primarily owing to Injectable and Generic segment. There is cost pressure mounting due to the high costs of organic chemicals as
from Tax Saving Investments | Tax Saving Tips & News | Income Tax India – Oneindia Money https://ift.tt/0RwqDFX
via IFTTT
from Tax Saving Investments | Tax Saving Tips & News | Income Tax India – Oneindia Money https://ift.tt/0RwqDFX
via IFTTT